Niederer Kraft Frey advised Veristat on the acquisition of SFL Regulatory Affairs & Scientific Communication GmbH and its group companies.
Headquartered in the US, Veristat is a scientific-minded global clinical research organisation (CRO) with more than 27 years of experience in clinical trial planning and execution.
SFL is a leading Swiss-based consultancy with affiliates in Austria, Germany, and the UK providing integrated solutions to pharma, biotech and medtech companies for global and local activities.
The NKF team was led by M&A partner Patrik Peyer, working with associates Binderiya Gan-Ayush, Michel Herren, junior associates Luisa Egli, Lukas Würgler and Yannik Bleiker (all M&A), counsel Janine Reudt-Demont (Life Sciences and Data Protection), partners Adrian Koller (Finance) and Nicolas Birkhäuser (Antitrust/Competition) and associate Annina Fey (Employment).